Last reviewed · How we verify

quetiapine (Seroquel) XR

Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc. · FDA-approved active Small molecule

quetiapine (Seroquel) XR is a Atypical antipsychotic Small molecule drug developed by Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.. It is currently FDA-approved for Schizophrenia, Bipolar I disorder (acute mania and maintenance), Major depressive disorder (adjunctive treatment). Also known as: Seroquel XR, Seroquel, Seroquel XR tablet, Seroquel_XR (Quetiapine Fumarate XR).

Quetiapine is an atypical antipsychotic that blocks dopamine and serotonin receptors in the brain to reduce psychotic symptoms and stabilize mood.

Quetiapine is an atypical antipsychotic that blocks dopamine and serotonin receptors in the brain to reduce psychotic symptoms and stabilize mood. Used for Schizophrenia, Bipolar I disorder (acute mania and maintenance), Major depressive disorder (adjunctive treatment).

At a glance

Generic namequetiapine (Seroquel) XR
Also known asSeroquel XR, Seroquel, Seroquel XR tablet, Seroquel_XR (Quetiapine Fumarate XR)
SponsorDr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
Drug classAtypical antipsychotic
TargetDopamine D2 receptor, serotonin 5-HT2A receptor
ModalitySmall molecule
Therapeutic areaPsychiatry
PhaseFDA-approved

Mechanism of action

Quetiapine antagonizes dopamine D1 and D2 receptors as well as serotonin 5-HT1A and 5-HT2A receptors. The extended-release formulation provides sustained drug levels, allowing once-daily dosing. This receptor antagonism reduces hyperactivity in mesolimbic and mesocortical dopamine pathways implicated in psychosis and mood dysregulation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about quetiapine (Seroquel) XR

What is quetiapine (Seroquel) XR?

quetiapine (Seroquel) XR is a Atypical antipsychotic drug developed by Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc., indicated for Schizophrenia, Bipolar I disorder (acute mania and maintenance), Major depressive disorder (adjunctive treatment).

How does quetiapine (Seroquel) XR work?

Quetiapine is an atypical antipsychotic that blocks dopamine and serotonin receptors in the brain to reduce psychotic symptoms and stabilize mood.

What is quetiapine (Seroquel) XR used for?

quetiapine (Seroquel) XR is indicated for Schizophrenia, Bipolar I disorder (acute mania and maintenance), Major depressive disorder (adjunctive treatment), Generalized anxiety disorder.

Who makes quetiapine (Seroquel) XR?

quetiapine (Seroquel) XR is developed and marketed by Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc. (see full Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc. pipeline at /company/dr-d-mcintosh-dr-k-kjernisted-clinical-research-inc).

Is quetiapine (Seroquel) XR also known as anything else?

quetiapine (Seroquel) XR is also known as Seroquel XR, Seroquel, Seroquel XR tablet, Seroquel_XR (Quetiapine Fumarate XR).

What drug class is quetiapine (Seroquel) XR in?

quetiapine (Seroquel) XR belongs to the Atypical antipsychotic class. See all Atypical antipsychotic drugs at /class/atypical-antipsychotic.

What development phase is quetiapine (Seroquel) XR in?

quetiapine (Seroquel) XR is FDA-approved (marketed).

What are the side effects of quetiapine (Seroquel) XR?

Common side effects of quetiapine (Seroquel) XR include Somnolence/sedation, Dry mouth, Dizziness, Weight gain, Headache, Orthostatic hypotension.

What does quetiapine (Seroquel) XR target?

quetiapine (Seroquel) XR targets Dopamine D2 receptor, serotonin 5-HT2A receptor and is a Atypical antipsychotic.

Related